| Financial Year |
March 31 2023 |
| Monetary Funds |
126,727,673.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
92,244,612.90 |
| Advances to Suppliers |
63,196,720.63 |
| Other Receivables |
192,081,329.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
91,141,946.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,506,751.74 |
| Total Current Assets |
584,344,900.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,258,604,476.42 |
| Investment Properties |
-- |
| Fixed Assetes |
496,020,707.12 |
| Under-construction Projects |
9,037,773.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,283,010.13 |
| R&D expenses |
19,202,997.31 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,326,481.70 |
| Deferred Income Tax Assets |
114,808,982.62 |
| Other Non-Current Assets |
1,636,065.46 |
| Sub-Total of Non-Current Assets |
2,742,913,057.30 |
| Total Assets |
3,327,257,957.69 |
| Short-Term Loans |
291,882,162.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,520,000.00 |
| Accounts Payable |
273,084,021.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,082,632.44 |
| Taxes Payable |
88,600,306.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
341,045,938.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,852,696.58 |
| Other Current Liabilities |
3,722,167.96 |
| Sub-Total of Current Liabilities |
1,104,411,568.36 |
| Long-term Loans |
42,065,333.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
205,593,213.02 |
| Deferred Income Tax Liabilities |
88,060,774.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
365,314,623.21 |
| Total Liabilities |
1,469,726,191.57 |
| Paid-In Capital(Or Share Stock) |
1,507,589,677.00 |
| Capital Surplus |
712,814,138.91 |
| Surplus Reserve |
145,344,706.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-393,975,976.76 |
| Minority Stockholder's Interest |
-111,563,201.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,969,094,967.61 |
| Owner's Equity（Stockholder's Equity） |
1,857,531,766.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,327,257,957.69 |
